Screener
LeMaitre Vascular LMAT Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | (unaudited) / June 30, 2026 | December 31, 2025 |
|---|---|---|
| Preferred stock, $0.01 par value; 3,000,000 shares authorized; none issued and outstanding | — | — |
| Common stock, $0.01 par value; 37,000,000 shares authorized, 24,494,202 and 24,396,904 shares issued, 22,864,935 and 22,772,607 shares outstanding, respectively | 245 | 244 |
| Additional paid-in capital | 236,161 | 228,407 |
| Retained earnings | 206,017 | 184,715 |
| Accumulated other comprehensive loss | (4,165) | (2,411) |
| Treasury stock, at cost; 1,629,267 and 1,624,297 shares, respectively | (17,916) | (17,439) |
| Total stockholders’ equity | 420,342 | 393,516 |
| Total liabilities and stockholders’ equity | $640,549 | $615,690 |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's total equity?
- LeMaitre Vascular (LMAT) reported total equity of $420.34M in Q2 2026.
- How has LeMaitre Vascular's total equity changed year-over-year?
- LeMaitre Vascular's total equity increased by 15.9% year-over-year, from $362.69M to $420.34M.
- What is the long-term trend for LeMaitre Vascular's total equity?
- Over 5 years (2020 to 2025), LeMaitre Vascular's total equity has grown at a 17.9% compound annual growth rate (CAGR), from $172.57M to $393.52M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about LeMaitre Vascular's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude